Gastric Ulcer
📧 Sign up to get email alerts when something new happens for Gastric Ulcer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-01-07FDA Approved: FAMOTIDINE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' original application for famotidine, establishing a new generic entry for the acid-reducing medication…
-
FDA approval · 2021-11-14FDA Approved: LANSOPRAZOLE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for lansoprazole from Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2021-11-12FDA Approved: LANSOPRAZOLE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Camber Pharmaceuticals' lansoprazole, a generic proton pump inhibitor, under ANDA 203083.
-
FDA approval · 2021-11-09FDA Approved: LANSOPRAZOLE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s supplemental application for lansoprazole (generic). This action approves a generic Lansoprazole produ…
-
FDA approval · 2021-11-03FDA Approved: FAMOTIDINE — Original Application (Ascent Pharmaceuticals, Inc.)
The FDA approves the original generic application for famotidine by Ascent Pharmaceuticals, Inc., enabling a generic version of this H2 bloc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-10-21FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) manufactured by AmerisourceBergen.
-
FDA approval · 2021-10-15FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr.Reddy's Laboratories Ltd.)
The FDA approved a supplemental application for lansoprazole by Dr. Reddy's Laboratories Ltd. This approval updates the current marketing au…
-
FDA approval · 2021-10-15FDA Approved: FAMOTIDINE — Original Application (XLCare Pharmaceuticals, Inc.)
FDA approved an original application for famotidine from XLCare Pharmaceuticals, Inc., marking the approval of a generic famotidine product.
-
FDA approval · 2021-09-14FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for rabeprazole sodium (generic) from Ascend Laboratories, LLC.
-
FDA approval · 2021-08-30FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic rabeprazole sodium product from Aurobindo Pharma Limited.
-
FDA approval · 2021-07-26FDA Tentative Approval: PANTOPRAZOLE SODIUM — Supplemental Application (Civica, Inc.)
The FDA issued tentative approval for Civica, Inc.'s pantoprazole sodium supplemental application (NDA 209463), enabling tentative U.S. mark…
-
FDA approval · 2021-07-20FDA Approved: FAMOTIDINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for famotidine from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2021-07-07FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Supplemental Application (BJWC)
FDA approved a supplemental application for Berkley and Jensen Omeprazole (omeprazole). This approval supports updates to labeling and expan…
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection [Phase 3]
Phase 3 trial comparing TAK-438 (vonoprazan) to lansoprazole in gastric ulcer patients (with or without Helicobacter pylori) completed; resu…
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use"
Completed long-term surveillance trial evaluating vonoprazan for prevention of recurrence of gastric/duodenal ulcers in NSAID users; results…
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy [Phase 4]
Phase 4 clinical trial comparing eupatilin and rebamipide for prevention of gastroenteropathy, sponsored by Seoul National University Borama…
-
FDA approval · 2021-04-20FDA Approved: FAMOTIDINE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' Original Application for famotidine, a generic H2 blocker, enabling marketing for ulcers and gastroeso…
-
FDA approval · 2021-03-19FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Biocon Pharma Inc.,)
FDA approved Biocon Pharma's Original Application for esomeprazole magnesium, a generic proton pump inhibitor, enabling marketing of a lower…
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Helicobacter Pylori Eradication With a New Sequential Treatment [Phase 3]
Phase 3 trial update on a new sequential treatment for Helicobacter pylori eradication completed.
-
FDA approval · 2021-02-19FDA Approved: FAMOTIDINE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for famotidine submitted by Chartwell RX, LLC (ANDA 075786). It authorizes changes to the approved g…
-
FDA approval · 2021-02-01FDA Approved: LANSOPRAZOLE — Original Application (NorthStar Rx LLC)
FDA approved NorthStar Rx LLC's Original Application for a generic lansoprazole. Lansoprazole is a proton pump inhibitor used to treat pepti…
-
FDA approval · 2020-12-10FDA Approved: OMEPRAZOLE — Original Application (Golden State Medical Supply, Inc.)
FDA approved the original application for a generic omeprazole product (ANDA 212977) manufactured by Golden State Medical Supply, Inc.
-
FDA approval · 2020-12-09FDA Approved: OMEPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Omeprazole from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2020-12-01FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for generic omeprazole from Lannett Company under ANDA075410, authorizing continued marketing under …
-
FDA approval · 2020-11-27FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Protonix delayed-release (pantoprazole sodium) submitted by Wyeth Pharmaceuticals LLC, a subsidi…